The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...

Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients market is poised for significant growth, expanding biopharmaceutical pr ...

Roughly three months after signing an executive order to streamline the | President Donald Trump has inked a new executive order calling on the HHS’ Administration for Strategic Preparedness and ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

In his latest effort to incentivize domestic manufacturing of drugs and their key ingredients, U.S. President Donald Trump issued an executive order Aug. 13 to replenish the country’s nearly empty ...

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...

AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...

The new North Chicago facility, slated to open in 2027, will boost domestic production of key drug ingredients for immunology ...

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...

Drugmaker AbbVie plans to construct a $195 million facility near its headquarters in North Chicago to manufacture active pharmaceutical ingredients, The Chicago Tribune reported Aug. 12. Construction ...